Research demonstrates combined Bpc-157 and Tb-500 use produces approximately 30 percent faster healing versus either peptide used individually, with enhanced fibroblast activity and immune cell migration
Although the tumor volume was lower, there was no statistical significance between the BPC 157-treated and untreated xenograft mice [15]
Also, its slightly slower than intramuscular administration
5-Amino-1-MQ iodide, 5-Amino-1-methylquinolinium, iodide (1:1), 5-Amino-1MQ iodide
For example, a potential drug candidate, AEZS-108, couples a peptide LHRH with the chemotherapeutic agent doxorubicin to directly target cells that express LH-RH receptors, specifically prostate cancer cells [91, 92]